Home | Welcome to Contract Pharma   
Last Updated Monday, November 24 2014

Topics - Drug Discovery

Refine by Date:
From: To:
Published November 18, 2014
Alliance of CMO with leading drug product formulator creates fully integrated CDMO focusing on advanced drug delivery and combination products. Read More »
Published November 17, 2014
Focus of collaboration is to develop an antibody actinium 225 construct using novel labelling technology to enable platform expansion. Read More »
Published November 10, 2014
Will provide research activities for another five years Read More »
Published October 30, 2014
Will collaborate with Pontifax to invest in technologies to advance capabilities Read More »
Published October 21, 2014
Adds new immunotherapy platforms for cancer research Read More »
Published October 15, 2014
Will perform drug combination screening on lead oncology asset Read More »
Published October 7, 2014
Successfully nominates oral drug candidate for preclinical development Read More »
Published October 2, 2014
Further expands SMARTag Antibody-Drug Conjugate (ADC) technology platform Read More »
Published September 29, 2014
Expands gene-editing capabilities Read More »
Published September 25, 2014
Sees growth in small molecule discovery technology Read More »
Published September 22, 2014
Silarus Therapeutics and Thyritope Biosciences will receive $10M in financing and R&D support Read More »
Published September 15, 2014
Evotec to provide screening of compound libraries in multiple assay formats Read More »
Published September 8, 2014
Therapeutic antibodies target autoimmune disease Read More »
Published August 19, 2014
Evotec to provide compound management services to support malaria research Read More »
Published July 15, 2014
To employ Fluofarma discovery and translational services Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On